Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Bioqual, Inc. (BIOQ)

Other OTC - Other OTC Delayed Price. Currency in USD
80.00+1.50 (+1.91%)
At close: 09:47AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close78.50
Open80.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range80.00 - 80.00
52 Week Range57.00 - 108.50
Volume111
Avg. Volume52
Market Cap71.68M
Beta (5Y Monthly)-0.21
PE Ratio (TTM)13.02
EPS (TTM)6.14
Earnings DateJan 19, 2023 - Jan 23, 2023
Forward Dividend & Yield1.00 (1.27%)
Ex-Dividend DateOct 05, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for BIOQ

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BIOQUAL INC
    Analyst Report: Charles River Laboratories International, Inc.Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
    Rating
    Fair Value
    Economic Moat
    8 days agoMorningstar
View more
  • Business Wire

    BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2023

    ROCKVILLE, Md., October 21, 2022--BIOQUAL, Inc. (OTC-Pink:BIOQ):

  • Business Wire

    BIOQUAL, Inc. Announces New CFO

    ROCKVILLE, Md., October 06, 2022--BIOQUAL, Inc., Announces Promotion of Mr. Charles (Chris) C. Kirk, Jr., CPA. to the Position of Chief Financial Officer. Mr. Kirk has over 25 years of experience in leadership roles in finance and accounting departments for both Government contracting and services-oriented companies as well as in the public accounting sector. Mr. Kirk has served as Director of Finance and Accounting for BIOQUAL over the past year and has a degree in Accounting/Finance from the U

  • Business Wire

    BIOQUAL Declares Dividend

    ROCKVILLE, Md., September 27, 2022--BIOQUAL’s Board of Directors has declared a dividend of $1.00 per share for shareholders of record on October 6, 2022, payable on October 27, 2022. This is the twenty-first dividend declared by BIOQUAL.

Advertisement
Advertisement